Predicting the development of hepatocellular cancer in hepatitis B carriers

Gut

Volumn 57, Issue 1, 2008, Pages 12-15

  De Mitri, M S ^a   Bernardi, M ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME REARRANGEMENT; DNA REPAIR; ETHNIC DIFFERENCE; GENE MUTATION; GENOTYPE; HEPATITIS B; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NOTE; ONCOGENE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; VIREMIA; VIRUS CARRIER; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; CARRIER STATE; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MUTATION; PREDICTIVE VALUE OF TESTS;

EID: 38349122491     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.128710     Document Type: Note

References (30)

1. Hino O, Kajino K. Hepatitis virus-related hepatocarcinogenesis. Intervirology 1994;37:133-5.
2. Moradpour D, Blum HE. Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005;17:477-83.
3. Kirosawa K. Trend of liver cirrhosis as precancerous lesions. Hepatol Res 2002;24:40-5.
4. Blum HE, Offensperger WB, Walter S, et al. Hepatocellular carcinoma and hepatitis B virus infection: molecular evidence for monoclonal origin and expansion of malignantly transformed hepatocytes. J Cancer Res Clin Oncol 1987;113:466-72.
5. Murakami Y, Saigo K, Takashima H, et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005;54:1162-8.
6. Buti M, Rodriguez-Frias F, Jardi R, et al. Hepatitis B virus variability and disease progression: the impact of pre-core mutants and HBV genotypes. J Clin Virol 2005;34:79-82.
7. Kao JH, Chen PJ, Lai MY, et al. HBV genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554-9.
8. Ohkubo K, Kato Y, Ichikawa T, et al. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer 2002;94:2663-8.
9. Gunther S, Fisher L, Pult I, et al. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999;52:25-137.
10. Sanchez-Tapias JM, Costa J, Mas A, et al. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in Western patients. Gastroenterology 2002;123:1848-56.
11. Lok ASF, Akarka U, Greene S. Mutations in the precore region of hepatitis B virus serve to enhance the stability of the pre-genome encapsidation signal. Proc Natl Acad Sci USA 1994;91:4077-81.
12. Tong SP, Li JS, Vitvitski L, et al. Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: Relevance of pregenome encapsidation signal. Virology 1992;191:237-45.
13. Orito E, Mizokami M. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Intervirology 2003;46:408-12.
14. Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 2004;127:1733-38.
15. Chan HLY, Hui ML, Tse AML, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004;53:1494-8.
16. Fujie H, Moriya K, Shintani Y, et al. Hepatitis B virus genotype and hepatocellular carcinoma in Japan. Gastroenterology 2001;120:1564-5.
17. Yuen MF, Sablon E, Yuan HJ, et al. The significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications and hepatocellular carcinoma. Hepatology 2003;37:562-7.
18. Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003;37:19-26.
19. Kuang SY, Jackson PE, Wang JB, et al. Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci USA 2004;101:3575-80.
20. Yuen MF, Sablon E, Tanaka Y, et al. Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong kong. J Hepatol 2004;41:119-25.
21. Buckwold VE, Xu Z, Chen M, et al. Effects of naturally occurred mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996;70:5845-51.
22. Tang H, Raney A, McLachlan A. Replication of the wild type and a natural hepatitis B nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture. J Virol 2001;75:8937- 48.
23. Buckwold VE, Xu Z, Yen TS, et al. Effect of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol 1997;78:2055-65.
24. Liu CJ, Chen BF, Chen PJ, et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case control study. J Infect Dis 2006;194:594-9.
25. Yuen MF, Tanaka Y, Mizokami M, et al. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis 2004;25:1595-8.
26. Ito K, Tanaka Y, Orito E, et al. T1653 mutation in the box α increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis 2006;42:1-7.
27. Sato S, Suzuki K, Akahane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Int Med 1995;122:241-8.
28. Tanaka Y, Mukaide M, Orito E, et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006;45:646-53.
29. Yuen MF, Tanaka Y, Shinkai N, et al. Bisk for hepatocellular carcinoma with respect to hepatitis B virus genotype B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 2008;57:98-102.
30. Chou YC, Yu MW, Wu CF, et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 2008;57:91-7.